Janus Henderson Group plc 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-02-14 12:30 pm Sale | 2019-12-31 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -3,143,758 (Position Closed) | Filing |